维普期刊资源整合服务平台（V6.5）

69篇 您的检索式：作者名="Trovik"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Growth Differentiation Factor-15 as Biomarker in Uterine Sarcomas显示文摘	Jone Trovik Helga Birgitte Salvesen Tine Cuppens Frederic Amant Anne Cathrine Staff	2014	International Journal of Gynecological Cancer2014，，2：	2
2	Elevated plasma growth differentiation factor - 15 correlates with lymph node metas- tases and poor survival in endometrial cancer 显示文摘	STAFF A C TROVIK J ERIKSSON A G	2011	Clin Cancer Res2011，17，14：	1
3	A novel wnt regulatory axis in endometrioid endometrial cancer 显示文摘	Zhao Y Yang Y Trovik J	2014	Cancer Res2014，74，18：	1
4	Stathmin is superior toAKT and phospho-AKT staining for the detection of phos-phoinositide 3-kinase activation and aggressive endometrialcancer显示文摘	Trovik J Wik E Stefansson I	2010	Histopathology2010，57，4：	1
5	Stathmin overexpression i-dentifies high-risk patients and lymph node metastasis in endom-etrial cancer显示文摘	Trovik J Wik E Stefansson I	2011	Clin Cancer Res2011，17，10：	1
6	Loss of GPER identities new targets for therapy among a subgroup of ERα--positive endometrial cancer patients with poor outcome显示文摘	Krakstad C Trovik J Wik E	2012	Br J Cancer2012，106，：	1
7	Evolution in endometrial cancer evidence from an immunohistochemical study显示文摘	Vandenput I Trovik J Leunen K	2011	Int J Gynecol Cancer2011，21，2：	1
8	Elevated plasmagrowth differentiation factor-15 correlates with lymph node metas-tases and poor survival in endometrial cancer显示文摘	STAFF A C TROVIK J ZAHL E A	2011	Clin CancerRes2011，17，14：	1
9	Markers for indi- vidualised therapy in endometrial carcinoma 显示文摘	Salvesen HB Haldorsen IS Trovik J	2012	Lancet Oneol2012，13，8：	1
10	Radiotherapy to improve local control regardless of surgical margin and malignancy grade in extremity and trunk wall soft tissue sarcoma:a Scandinavian sarcoma group study显示文摘	Jebsen NL Trovik CS Bauer HC	2008	Int J Radiat Oncol Biol Phys2008，71，4：	1
11	Elevated plasma growth differentiation factor-15 correlates with lymph node metastases and poor survival in endometrial cancer显示文摘	Staff AC Trovik J Eriksson AG	2011	Clin Cancer Res2011，17，14：	1
12	Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome显示文摘	KRAKSTAD C TROVIK J WIK E	2012	British Journal of Cancer2012，106，10：	1
13	Stathmin overexpression i-dentifies high-risk patients and lymph node metastasis in endome-trial cancier显示文摘	Trovik J Wik E Stefansson IM	2011	Clin Cancer Res2011，17，10：	1
14	Loss of GPER identi- fies new targets for therapy among a subgroup of ERa- positive endometrial cancer patients with poor outcome 显示文摘	Krakstad C Trovik J Wik E	2012	Sr J Cancer2012，106，10：	1
15	Revision of FIGO surgical staging in 2009 for endometrial cancer validates to improve risk stratification显示文摘	Werner H M Trovik J Marcickiewicz J	2012	Gynecol Oncol2012，125，1：	1
16	Stathmin protein level, a potential predictive marker for taxane treatment response in endom- etrial cancer显示文摘	Werner HM Trovik J Halle MK	2014	PLoS One2014，9，90：	1
17	Surgical margins, lo- cal recurrence and metastasis in soft tissue sarcomas: 559 surgi- cally-treated patients from the Scandinavian Sarcoma Group Reg- ister显示文摘	Trovik CS Bauer HC Alvegard TA	2000	Eur J Cancer2000，36，6：	1
18	Elevated plasma growth differentiation factor-15 correlates with lymph node me- tastases and poor survival in endometrial cancer显示文摘	Staff A C Trovik J Zahl E A G		Clin Can- cer Res0，17，14：	1
19	Evolution in en- dometrial cancer evidence from an imm unohistochemical study显示文摘	Vandenput I Trovik J Leunen K	2011	Int J Gynecol Cancer2011，21，2：	1
20	Evolution in endometrial cancer evidence from an immunohistochemical study显示文摘	Vandenput I Trovik J Leunen K	2011	Int J Gynecol Cancer2011，21，2：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示